135 related articles for article (PubMed ID: 17666856)
1. Effect of pore former on the properties of casted film prepared from blends of Eudragit NE 30 D and Eudragit L 30 D-55.
Zhang X; Wang Y; Wang J; Wang Y; Li S
Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1261-3. PubMed ID: 17666856
[TBL] [Abstract][Full Text] [Related]
2. Blends of aqueous polymer dispersions used for pellet coating: importance of the particle size.
Siepmann F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
J Control Release; 2005 Jul; 105(3):226-39. PubMed ID: 15946758
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of free mixed-film of pectin/chitosan/Eudragit RS intended for sigmoidal drug delivery.
Ghaffari A; Navaee K; Oskoui M; Bayati K; Rafiee-Tehrani M
Eur J Pharm Biopharm; 2007 Aug; 67(1):175-86. PubMed ID: 17346954
[TBL] [Abstract][Full Text] [Related]
4. Highly Soluble Drugs Directly Granulated by Water Dispersions of Insoluble Eudragit® Polymers as a Part of Hypromellose K100M Matrix Systems.
Mašková E; Naiserová M; Kubová K; Mašek J; Pavloková S; Urbanová M; Brus J; Vysloužil J; Vetchý D
Biomed Res Int; 2019; 2019():8043415. PubMed ID: 30949510
[TBL] [Abstract][Full Text] [Related]
5. Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation.
Saoji SD; Atram SC; Dhore PW; Deole PS; Raut NA; Dave VS
AAPS PharmSciTech; 2015 Dec; 16(6):1344-56. PubMed ID: 25922089
[TBL] [Abstract][Full Text] [Related]
6. Novel use of Eudragit NE 30D/Eudragit L 30D-55 blends as functional coating materials in time-delayed drug release applications.
El-Malah Y; Nazzal S
Int J Pharm; 2008 Jun; 357(1-2):219-27. PubMed ID: 18353571
[TBL] [Abstract][Full Text] [Related]
7. Quaternary polymethacrylate-magnesium aluminum silicate films: Water uptake kinetics and film permeability.
Rongthong T; Sungthongjeen S; Siepmann F; Siepmann J; Pongjanyakul T
Int J Pharm; 2015 Jul; 490(1-2):165-72. PubMed ID: 26004005
[TBL] [Abstract][Full Text] [Related]
8. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
[TBL] [Abstract][Full Text] [Related]
9. Influence of an acrylic polymer blend on the physical stability of film-coated theophylline pellets.
Kucera S; Shah NH; Malick AW; Infeld MH; McGinity JW
AAPS PharmSciTech; 2009; 10(3):864-71. PubMed ID: 19568939
[TBL] [Abstract][Full Text] [Related]
10. Relationship of film properties to drug release from monolithic films containing adjuvants.
Jenquin MR; Sarabia RE; Liebowitz SM; McGinity JW
J Pharm Sci; 1992 Oct; 81(10):983-9. PubMed ID: 1432624
[TBL] [Abstract][Full Text] [Related]
11. Investigation of a new pH-responsive nanoparticulate pore former for controlled release enteric coating with improved processability and stability.
Chen K; Chang HHR; Shalviri A; Li J; Lugtu-Pe JA; Kane A; Wu XY
Eur J Pharm Biopharm; 2017 Nov; 120():116-125. PubMed ID: 28887098
[TBL] [Abstract][Full Text] [Related]
12. Mechanical properties of dry and wet cellulosic and acrylic films prepared from aqueous colloidal polymer dispersions used in the coating of solid dosage forms.
Bodmeier R; Paeratakul O
Pharm Res; 1994 Jun; 11(6):882-8. PubMed ID: 7937530
[TBL] [Abstract][Full Text] [Related]
13. Studies comparing Kollicoat MAE 30 D with commercial cellulose derivatives for enteric coating on caffeine cores.
Scheiffele S; Kolter K; Schepky G
Drug Dev Ind Pharm; 1998 Sep; 24(9):807-18. PubMed ID: 9876531
[TBL] [Abstract][Full Text] [Related]
14. Poly vinyl acetate and ammonio methacrylate copolymer as unconventional polymer blends increase the mechanical robustness of HPMC matrix tablets.
Ali R; Dashevsky A; Bodmeier R
Int J Pharm; 2017 Jan; 516(1-2):3-8. PubMed ID: 27818241
[TBL] [Abstract][Full Text] [Related]
15. Coatings of Eudragit® RL and L-55 Blends: Investigations on the Drug Release Mechanism.
Wulff R; Leopold CS
AAPS PharmSciTech; 2016 Apr; 17(2):493-503. PubMed ID: 26265188
[TBL] [Abstract][Full Text] [Related]
16. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
[TBL] [Abstract][Full Text] [Related]
17. Characterization of moisture-protective polymer coatings using differential scanning calorimetry and dynamic vapor sorption.
Bley O; Siepmann J; Bodmeier R
J Pharm Sci; 2009 Feb; 98(2):651-64. PubMed ID: 18481311
[TBL] [Abstract][Full Text] [Related]
18. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
[TBL] [Abstract][Full Text] [Related]
19. Sustained release enteric coated tablets of pantoprazole: formulation, in vitro and in vivo evaluation.
Wilson B; Babubhai PP; Sajeev MS; Jenita JL; Priyadarshini SR
Acta Pharm; 2013 Mar; 63(1):131-40. PubMed ID: 23482318
[TBL] [Abstract][Full Text] [Related]
20. Influence of Eudragit NE 30 D blended with Eudragit L 30 D-55 on the release of phenylpropanolamine hydrochloride from coated pellets.
Zheng W; McGinity JW
Drug Dev Ind Pharm; 2003 Mar; 29(3):357-66. PubMed ID: 12741617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
